sramzan
What you are saying is exactly correct.
Alkane released a "Company Insight" on 22nd Dec 2010 and Ian Chalmers said "Our base case forecasts A$135 million in revenue, but again, we think this is very conservative. Back of the envelope operating costs are around A$60 million a year - remembering that we still have to quantify the actual numbers through the feasibility study precess"
Link to whole article http://www.alkane.com.au/reports/asx/pdf/20101222.pdf
At least this gives us some idea of the costs but I'm not sure exactly if this is the total cost to Alkane to produce A$135 million in revenue.
Cheers.
- Forums
- ASX - By Stock
- article on rare earth.
sramzanWhat you are saying is exactly correct.Alkane released a...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALK (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.5¢ |
Change
-0.025(4.81%) |
Mkt cap ! $299.5M |
Open | High | Low | Value | Volume |
50.0¢ | 50.0¢ | 48.0¢ | $731.1K | 1.485M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 33631 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.5¢ | 12456 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 33631 | 0.490 |
2 | 12800 | 0.485 |
4 | 113156 | 0.480 |
2 | 40000 | 0.475 |
6 | 127015 | 0.470 |
Price($) | Vol. | No. |
---|---|---|
0.495 | 12456 | 3 |
0.500 | 21800 | 2 |
0.505 | 7800 | 1 |
0.515 | 2015 | 1 |
0.520 | 53288 | 5 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ALK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online